Review about Votrient

This page shows detailed information about a specific drug review.

Votrient

3/11/2022 | | 57moderated by Henry
Pazopanib (400MG) for Pulmonary artery sarcoma

I started Votrient at 400 mg for pulmonary artery sarcoma. I began at 400 mg as I have another rare disease, Fibromuscular dysplasia, that increases blood pressure so my oncologist started me at 400 mg to be safe. Within two weeks, I broke out in a rash and two weeks later my liver tests showed extremely elevated numbers. My CT showed stability and my dose was lowered to 200 mg. Will continue to be monitored for liver levels and CT stability.

0 reactions

Reactions to this review

No reactions found at this moment.

The list of reactions to this review is empty. Please check back later.

The content on this page is user-generated content, read and revised before approval to comply with our standards for a drug review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Add your reaction to this review



IMPORTANT: this email address is from the person giving this reaction and will be kept private. It will only be used by us to contact you about your reaction or if you check the option below.

Copyright © 2008-2022 Insight Pharma Services BV.
All rights reserved.
Icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.